The Global Health Observatory
Explore a world of health data
A
- Abortion rate estimate
- Abortion: pregnancy, unintended rate, estimate
- Acute respiratory infection: care-seeking for children with symptoms (%)
- Adolescent birth rate (per 1000 women)
- Adolescent mortality rate (per 1 000 age specific cohort)
- Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
- Air pollution attributable DALYs (per 100 000 population, age-standardized), ambient
- Air pollution attributable DALYs (per 100 000 population, age-standardized), household and ambient
- Air pollution attributable DALYs, ambient
- Air pollution attributable DALYs, household
- Air pollution attributable DALYs, household and ambient
- Air pollution attributable death rate (per 100 000 population, age-standardized), ambient
- Air pollution attributable death rate (per 100 000 population, age-standardized), household
- Air pollution attributable deaths, ambient
- Air pollution attributable deaths, household
- Air pollution attributable deaths, household and ambient
- Air pollution attributable mortality rate (per 100 000 population, age-standardized), household and ambient, SDG indicator 3.9.1
- Air pollution, attributable DALYs (per 100 000 population, age-standardized), household
- Air pollution: concentrations of fine particulate matter (PM2.5), SDG 11.6.2
- Alchohol license required for retail sales
- Alcohol advertising restrictions at cinemas
- Alcohol advertising restrictions at point-of-sale
- Alcohol advertising restrictions in print media
- Alcohol advertising restrictions on billboards
- Alcohol advertising restrictions on cable television
- Alcohol advertising restrictions on local radio
- Alcohol advertising restrictions on national radio
- Alcohol advertising restrictions on national television
- Alcohol advertising restrictions on social media
- Alcohol advertising restrictions on the internet
- Alcohol age limits, off-premise sales
- Alcohol age limits, on-premise service
- Alcohol awareness-raising activities
- Alcohol consumption surveys, adult
- Alcohol consumption surveys, youth
- Alcohol content displayed on containers
- Alcohol control policy: consumer information about calories, additives, etc on containers
- Alcohol control policy: Detection of marketing infringements
- Alcohol control policy: duty paid or excise stamp on alcohol container
- Alcohol control policy: random breath testing (RBT) use
- Alcohol control, restrictions on product placement in films/movies
- Alcohol control, restrictions on product placement on cable television
- Alcohol control, restrictions on product placement on national television
- Alcohol control, restrictions on sales promotion from owners of pubs and bars (alcohol for free)
- Alcohol control, restrictions on sales promotion from producers (parties, events)
- Alcohol control, restrictions on sales promotion from retailers (sales below cost)
- Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI
- Alcohol license required for production
- Alcohol licenses issued for production, change since 2010
- Alcohol licenses issued for retail sale, change since 2010
- Alcohol licenses issued for wholesale/distribution, change since 2010
- Alcohol licensing required for exports of alcoholic beverages
- Alcohol licensing required for imports of alcoholic beverages
- Alcohol licensing required for wholesale/distribution of alcoholic beverages
- Alcohol off-premise sales restrictions at petrol stations
- Alcohol off-premise sales restrictions at specific events
- Alcohol off-premise sales restrictions on days
- Alcohol off-premise sales restrictions on hours
- Alcohol off-premise sales restrictions on outlet density
- Alcohol off-premise sales restrictions on places
- Alcohol on-premise sales restrictions at specific events
- Alcohol on-premise sales restrictions on days
- Alcohol on-premise sales restrictions on hours
- Alcohol on-premise sales restrictions on outlet density
- Alcohol on-premise sales restrictions on places
- Alcohol on-premise sales restrictions to intoxicated persons
- Alcohol policy, action plan for implementation
- Alcohol policy, drink driving, graduated licensing
- Alcohol policy, drink driving: legal blood alcohol concentration (BAC) limits
- Alcohol policy, framework of national alcohol policy
- Alcohol policy: adopted written national policy on alcohol
- Alcohol policy: government monopoly on production
- Alcohol policy: government monopoly on retail sales
- Alcohol policy: government support for community action
- Alcohol policy: health warning labels on alcohol advertising
- Alcohol policy: health warning labels on alcohol containers
- Alcohol policy: health warning labels on drink-driving
- Alcohol policy: health warning labels on pregnancy
- Alcohol policy: health warning labels on under-age drinking
- Alcohol policy: legal requirement for size of health warning labels
- Alcohol policy: national drinking guidelines
- Alcohol policy: national legislation to prevent illegal alcohol
- Alcohol policy: national legislation to prevent illegal alcohol sales
- Alcohol policy: penalties for drink driving
- Alcohol policy: penalties for drink driving, repeated offense
- Alcohol policy: penalties for marketing infringements on alcohol
- Alcohol policy: sectors represented
- Alcohol policy: sobriety checkpoints
- Alcohol Policy: standard alcoholic drinks displayed on containers
- Alcohol policy: taxation of ethanol production
- Alcohol prevention server training
- Alcohol prevention: legislation on alcohol testing at workplaces
- Alcohol prevention: national guidelines for alcohol problem prevention and counselling at workplaces
- Alcohol prevention: national guidelines for the prevention and reduction of alcohol-related harm in schools
- Alcohol prevention: Standard drink defined
- Alcohol price measures
- Alcohol research system of epidemiological data collection for alcohol use
- Alcohol research: national organization for monitoring alcohol
- Alcohol research: system of data collection based on health service delivery
- Alcohol research: systems for monitoring alcohol consumption and harms
- Alcohol restrictions on alcohol use in public places
- Alcohol restrictions on sponsorship of sporting events
- Alcohol restrictions on sponsorship of youth events
- Alcohol tax: value-added tax (VAT) on alcohol (%)
- Alcohol use disorders (15+), 12 month prevalence (%) with 95%
- Alcohol use is banned
- Alcohol, abstainers lifetime (%)
- Alcohol, abstainers past 12 months (%)
- Alcohol, average daily intake in grams among drinkers, three-year average
- Alcohol, average daily intake in grams, population (15+)
- Alcohol, consumers past 12 months (%)
- Alcohol, consumption of pure alcohol by type of beverage (%)
- Alcohol, drinkers only per capita (15+ years) consumption in litres of pure alcohol, three-year average
- Alcohol, former drinkers (%)
- Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI
- Alcohol, heavy continuous drinkers past year (15+) (%)
- Alcohol, heavy continuous drinkers past year, 15-19 years (%)
- Alcohol, heavy continuous drinkers, drinkers only, past year (15+)
- Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized
- Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)
- Alcohol, heavy episodic drinking, drinkers only, past 30 days, (youth 15 -19 years) (%)
- Alcohol, heavy episodic drinking, past 30 days, (youth 15 -19 years) (%)
- Alcohol, level of adoption of national alcohol policy
- Alcohol, level of taxation adjusted for inflation
- Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), by beverage type
- Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average
- Alcohol, regional prevalence of alcohol dependence (%)
- Alcohol, regional prevalence of alcohol use disorders (%)
- Alcohol, total per capita (15+ years) consumption (in litres of pure alcohol)
- Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)
- Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections
- Alcohol, tourist consumption (in litres of pure alcohol), three-year average
- Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol), three-year average
- Alcohol, years heavy continuous drinkers, drinkers only, past year, 15-19 (%)
- Alcohol: monopoly on exports of alcoholic beverages
- Alcohol: monopoly on imports of alcoholic beverages
- Alcohol: monopoly on wholesale /distribution of alcoholic beverages
- Alcohol-attributable all-cause deaths (all ages), (number)
- Alcohol-attributable DALYs (%)
- Alcohol-attributable DALYs lost from all causes (all ages) (number)
- Alcohol-attributable fractions (AAFs) all-cause deaths, prevalence of death (%), by region
- Alcohol-attributable fractions (AAFs) cancer, prevalence of death (%), by region
- Alcohol-attributable fractions (AAFs) liver cirrhosis, prevalence of death (%), by region
- Alcohol-attributable fractions (AAFs) road traffic crash, prevalence of death (%), by region
- Alcohol-attributable fractions, prevalence of death (%), by country
- Alcohol-attributable, age-standardized DALYs, per 100 000 population
- Alcohol-attributable, age-standardized death rates, per 100,000 population
- Alcoholic beverage legally defined
- Alcohol-related conditions, age-standardized death rates, per 100 000 population
- Alcohol-related deaths: liver cirrhosis, death rates (15+), per 100,000 population, age-standardized
- AMR WHO-GASP reporting countries
- Anaemia in children aged 6–59 months, prevalence (%) (2021 edition)
- Anaemia in women of reproductive age (aged 15-49 years) (thousands), by pregnancy status
- Anaemia in women of reproductive age (aged 15-49), prevalence (%), by pregnancy status
- Anaemia, children aged 6–59 months with anaemia (thousands) (2021 edition), number
- Antenatal care coverage - at least four visits (%)
- Antibiotic use: ≥70% of total antibiotic use being from WHO AWaRe Access group antibiotics (70% Access target)
- Antibiotic use: Pattern of antibiotic use at national level (relative use by AWaRe classification)
- Antibiotic use: Total use of antibiotics expressed as DDD per 1000 inhabitants per day
- Antimicrobial resistance and decreased susceptibility to antimicrobials testing in Neisseria gonorrhoea, number of isolates tested
- Antimicrobial resistance or decreased susceptibility to antimicrobials in Neisseria gonorrhoea: proportion of isolates with resistance of those tested
- Assistive technology education/training, availability
- Assistive technology government/registered services, availability
- Assistive technology legislation: coverage of people in need of assistive technology by a national or other legislation(s)
- Assistive technology products barriers to access
- Assistive technology products funding (%)
- Assistive technology public funding, availability
- Assistive technology responsible ministry/authority, existence
- Assistive technology, regulations/standards/guidelines/protocols, existence
- Assistive technology: financial mechanisms for assistive technology, existence
- Assistive technology: initiatives/collaborations on assistive tech, existence
- Assistive technology: legislation on access to assistive technology, existence
- Assistive technology: met need of assistive products, prevalence (%)
- Assistive technology: need of assistive products, prevalence (%)
- Assistive technology: satisfaction with assistive products and related services (%)
- Assistive technology: satisfaction with assistive products for different environments and activities (%)
- Assistive technology: sources of assistive products (%)
- Assistive technology: travel distance to obtain assistive products (%)
- Assistive technology: use of assistive products, prevalence (%)
- Assistive technology: workforce availability for
B
- BCG immunization coverage among 1-year-olds (%)
- Beds, hospital beds (per 10 000 population)
- Bejel, status of endemicity
- Biomedical engineers density (per 10 000 population)
- Biomedical engineers, number
- Biomedical technicians density (per 10 000 population)
- Biomedical technicians, number
- Births attended by skilled health personnel (%)
- Births by caesarean section (%)
- Births delivered in a health facility (facility/institutional births), proportion (%)
- Births, preterm (number)
- Births, preterm, rate per 100 live births
- Bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins, proportion (%)
- Bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA), proportion (%)
- Breastfeeding, early initiation of breastfeeding, children born in the last 24 months
- Breastfeeding, ever breastfed
- Breastfeeding: continued breastfeeding, 12-23 months
- Breastfeeding: exclusive breastfeeding under six months
- Breastfeeding: exclusively breastfed for the first two days after birth
- Buruli suspected cases, reported number
- Buruli ulcer confirmed cases, reported number
- Buruli ulcer, status of endemicity
C
- Cancer diagnosis and treatment services, availability
- Care-seeking by type of patient and source of care (%)
- Central coordinating entity for alcohol policy implementation
- Cervical cancer screening among women aged 30-49 years, prevalence (%)
- Cervical cancer screening program type
- Child deaths among adolescents 10-19 years of age, number
- Child deaths among children ages 5 to 14 years, number
- Child deaths among children ages 5 to 9 years, number
- Child deaths among children under-five, number
- Child deaths in children aged <5 years, by cause, number
- Child deaths in infants, infant mortality rate (between birth and 11 months per 1000 live births)
- Child deaths in neonates, neonatal deaths (0 to 27 days), number
- Child deaths, causes of death distribution among children aged < 5 years (%)
- Child deaths, causes of deaths, per 1 000 live births
- Child deaths, infant deaths (between birth and 11 months)
- Child deaths: under-five mortality rate (per 1000 live births) (SDG 3.2.1)
- Child feeding: egg and/or Flesh Food Consumption 6-23 months
- Child feeding: introduction of solid, semi-solid or soft foods, 6–8 months
- Child feeding: minimum acceptable diet 6-23 months
- Child feeding: minimum dietary diversity, 6–23 months
- Child feeding: minimum meal frequency, 6-23 months
- Child feeding: zero vegetable or fruit consumption, 6-23 months
- Child maltreatment: Extent of implementation of home-visiting programmes
- Child mortality in neonates, neonatal mortality rate (0 to 27 days) per 1000 live births) (SDG 3.2.2)
- Child mortality rate among children ages 5 to 9 years (per 1000 children aged 5)
- Child mortality rate for 5 to 14 year-olds (probability of dying per 1000 children aged 5-14 years)
- Children developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning, 36-59 months (%)
- Cholesterol (age-standardized estimate)
- Cholesterol, HDL, mean (age-standardized estimate)
- Cholesterol, HDL, mean (crude estimate)
- Cholesterol, mean total (age-standardized estimate)
- Cholesterol, mean total (crude estimate)
- Cholesterol, non-HDL, mean, trends (crude estimate)
- Climate change and health vulnerability and adaptation assessment conducted
- Climate change and health: agreement in place between MoH and other sector(s) in relation to policy or programs
- Climate change, health surveillance system which includes meteorological information, existence
- Climate change, health surveillance system, existence
- Climate change: designation of a focal point responsible for health and climate change within the Ministry of Health
- Climate change: Existence of a multi-stakeholder mechanism on health and climate change
- Climate change: national health and climate change plan or strategy developed
- Community Health Workers (number)
- Congenital Rubella Syndrome - number of reported cases
- Congenital syphilis number of cases, reported
- Congenital syphilis reported rate per 100 000 live births, reported
- Cooking fuels: population with primary reliance on clean fuels and technologies for cooking (in millions)
- Cooking fuels: population with primary reliance on clean fuels and technologies for cooking, proportion (%)
- Cooking fuels: population with primary reliance on fuels and technologies for cooking, by fuel type (in millions)
- Cooking fuels: population with primary reliance on fuels and technologies for cooking, by fuel type, proportion (%)
- Cooking fuels: population with primary reliance on polluting fuels and technologies for cooking (in millions)
- Cooking fuels: population with primary reliance on polluting fuels and technologies for cooking, proportion (%)
- Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%)
- Current health expenditure (CHE) per capita in US$
D
- Dementia assistive technology, availability of at least one
- Dementia basic research, expenditure (local currency, self-report)
- Dementia campaign: at least one functioning dementia awareness campaign, existence
- Dementia campaign: at least one functioning risk reduction campaign, existence
- Dementia care : adult hygiene products, availability
- Dementia care facilities [hospice centres]
- Dementia care facilities [hospitals]
- Dementia care facilities [long-term care]
- Dementia care facilities: people receiving services at outpatient health care, number, estimate
- Dementia care in hospital for people with dementia, existence of standards/ guidelines/ protocols
- Dementia care: activities of daily living support services in community, accessibility
- Dementia care: activities of daily living support services in community, availability
- Dementia care: anti-dementia medication approved for on-label use reimbursement, availability
- Dementia care: approval of anti-dementia medication
- Dementia care: behaviour and psychological management in community, accessibility
- Dementia care: behaviour and psychological management in community, availability
- Dementia care: carer training and education, accessibility
- Dementia care: community-based health or social care services, existence
- Dementia care: coordination standards/ guidelines/ protocols, availability
- Dementia care: dedicated resources for dementia carer support services, existence
- Dementia care: financial benefits/social protection for carers, accessibility
- Dementia care: formal agreement/joint plan for dementia care coordination, presence
- Dementia care: generic anti-dementia medication, availability
- Dementia care: hospitals following national dementia standards , estimate (%)
- Dementia care: housing adjustment for people with dementia, availability
- Dementia care: identification of different sectors in dementia care coordination (Health)
- Dementia care: identification of different sectors in dementia care coordination (Civil society)
- Dementia care: identification of different sectors in dementia care coordination (Education)
- Dementia care: identification of different sectors in dementia care coordination (Employment)
- Dementia care: identification of different sectors in dementia care coordination (Housing)
- Dementia care: Identification of different sectors in dementia care coordination (Justice)
- Dementia care: identification of different sectors in dementia care coordination (Other)
- Dementia care: identification of different sectors in dementia care coordination (Private sector)
- Dementia care: identification of different sectors in dementia care coordination (Social)
- Dementia care: implementation plan for dementia carer support services, existence
- Dementia care: information on legal rights for dementia carers, accessibility
- Dementia care: information on legal rights for dementia carers, existence
- Dementia care: majority provider of activities of daily living support services in community for dementia [public, private]
- Dementia care: majority provider of behavior and psychological management in community for dementia [public, private]
- Dementia care: majority provider of dementia carer training and education (NGO)
- Dementia care: majority provider of dementia carer training and education (Private sector)
- Dementia care: majority provider of information on financial benefits/social protection for dementia carers (Public sector)
- Dementia care: majority provider of information on legal rights for dementia carers (Public sector)
- Dementia care: majority provider of information on financial benefits/social protection for dementia carers (NGO)
- Dementia care: majority provider of information on legal rights for dementia carers (Private sector)
- Dementia care: majority provider of palliative and end-of-life care services in community for dementia [public, private]
- Dementia care: majority provider of psycho-social supports for dementia carers (NGO)
- Dementia care: majority provider of psycho-social supports for dementia carers (Public sector)
- Dementia care: majority provider of respite care for dementia carers (Private sector)
- Dementia care: majority provider of dementia carer training and education (Public sector)
- Dementia care: majority provider of diagnostic services in community for dementia [public, private]
- Dementia care: majority provider of information on financial benefits/social protection for dementia carers (Private sector)
- Dementia care: majority provider of information on legal rights for dementia carers (NGO)
- Dementia care: majority provider of psycho-social supports for dementia carers (Private sector)
- Dementia care: majority provider of respite care for dementia carers (Public sector)
- Dementia care: majority provider of social and financial protection for dementia [public, private]
- Dementia care: mechanisms to coordinate care across sectors, availability
- Dementia care: outpatient health centres
- Dementia care: outpatient social centres
- Dementia care: palliative and end of life services in community, accessibility
- Dementia care: people receiving activities of daily living support services in community, number, estimate
- Dementia care: people with dementia receiving social and financial protection, number, estimate
- Dementia care: psychosocial and rehabilitation services in community for dementia [public, private], majority provider
- Dementia care: psychosocial services and rehabilitation: behaviour and psychological management services in community, number, estimate
- Dementia care: psychosocial supports for carers, accessibility
- Dementia care: psycho-social supports for dementia carers, existence
- Dementia care: residential long-term care facilities following national dementia standards, estimate (%)
- Dementia care: respite care for carers, accessibility
- Dementia care: respite care for dementia carers, existence
- Dementia care: social and financial protection for dementia, accessibility
- Dementia carer support services, existence
- Dementia carers receiving financial benefits/social protection, number, estimate
- Dementia carers receiving information on legal rights, number, estimate
- Dementia carers receiving psycho-social supports, number, estimate
- Dementia carers receiving respite care, number, estimate
- Dementia carers receiving training and education, number, estimate
- Dementia carers: financial benefits/social protection for dementia carers, existence
- Dementia clinical/translational research, total expenditure (local currency, self-report)
- Dementia diagnosis, standards/ guidelines/ protocols, existence
- Dementia diagnostic rate, availability
- Dementia diagnostic services in community, accessibility
- Dementia diagnostic services in the community, availability
- Dementia facilities : people receiving services at outpatient social centers, number, estimate
- Dementia facilities: people living in residential long-term care, number, estimate
- Dementia inclusion in a branch of government [health, ageing, social services, mental health, noncommunicable disease]
- Dementia inclusion in diagnosis, care and support as a specific action of the dementia plan
- Dementia inclusion in ministry portfolio
- Dementia inclusion in training and education for non-health workers
- Dementia inclusion in workforce training as a specific action of the dementia plan
- Dementia inclusion risk reduction as a specific action of the dementia plan
- Dementia inclusion: dementia-friendly communities as a specific action of the dementia plan
- Dementia integrated into other national plan
- Dementia integrated into other national research plan/programme
- Dementia legislation to file appeals protecting the rights of people with dementia, existence
- Dementia legislation to promote community-based services for people with dementia, existence
- Dementia legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside, existence
- Dementia legislation, existence
- Dementia management, standards/ guidelines/ protocols, existence
- Dementia national nongovernmental organization, existence
- Dementia national plan, existence
- Dementia national plan: funding, availability
- Dementia national plan: targets for monitoring implementation
- Dementia NGO: governmental funding to dementia nongovernmental organization for activities/services
- Dementia nongovernmental organization equipped with office
- Dementia nongovernmental organization office branches (Local)
- Dementia nongovernmental organization office branches (National only)
- Dementia nongovernmental organization office branches (Sub-national)
- Dementia nongovernmental organization staff primarily salaried/volunteer
- Dementia nongovernmental organization's involvement in policy development
- Dementia other laws that apply to the rights of people with dementia, existence
- Dementia palliative and end-of-life care for people with dementia, existence of standards/ guidelines/ protocols
- Dementia palliative and end-of-life care services in community, availability
- Dementia palliative and end-of-life care services in community, people receiving, number, estimate
- Dementia plan: inclusion of empowerment as a guiding principle of the dementia plan
- Dementia plan: inclusion of equity as a guiding principle of the dementia plan
- Dementia plan: inclusion of improved information system as a specific action of the dementia plan
- Dementia plan: inclusion of multisectoral collaboration as a guiding principles of the dementia plan
- Dementia plan: inclusion of research and innovation as a specific action of the dementia plan
- Dementia plan: inclusion of support for dementia carers and families as a specific action of the dementia plan
- Dementia plan: inclusion of universal health coverage as a guiding principle of the dementia plan
- Dementia plans: identification of other plans in which dementia is integrated (Ageing)
- Dementia plans: identification of other plans in which dementia is integrated (Disability)
- Dementia plans: identification of other plans in which dementia is integrated (Mental health)
- Dementia plans: identification of other plans in which dementia is integrated (NCD)
- Dementia plans: identification of other plans in which dementia is integrated (Other)
- Dementia prevention and risk reduction of dementia, existence of standards/ guidelines/ protocols
- Dementia psychosocial and rehabilitation services in community, availability
- Dementia psychosocial services and rehabilitation: people receiving services in community, number, estimate
- Dementia reporting, availability and status
- Dementia representative in ministry, existence
- Dementia research investment: funding for dementia-specific research plan/programme, availability
- Dementia research output, published, total number
- Dementia research plan/programme, existence
- Dementia research, total expenditure (local currency, self-report)
- Dementia research: identification of other research plans in which dementia is integrated (Ageing)
- Dementia research: identification of other research plans in which dementia is integrated (NCD)
- Dementia research: identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease)
- Dementia research: investigational pharmaceutical trials for dementia
- Dementia research: investigational pharmaceutical trials, availability
- Dementia research: people with dementia involved in research routinely monitored, number
- Dementia routine monitoring: hospital admissions records for people with dementia, availability
- Dementia routine monitoring: outpatient intervention and treatment records for people with dementia for monitoring purposes, availability
- Dementia routine monitoring: outpatient visit records for people with dementia, availability
- Dementia routine monitoring: pharmaceutical records for people with dementia, availability
- Dementia routine monitoring: routine antipsychotic prescription records, availability
- Dementia services: psychosocial and rehabilitation services in community, accessibility
- Dementia social and financial protection, availability
- Dementia standards/ guidelines/ protocols, existence
- Dementia standards/ guidelines/ protocols, government-approved, existence
- Dementia sub-national plan(s), existence
- Dementia training for community workers
- Dementia training for financial service staff, existence
- Dementia training for first responders, existence
- Dementia training for legal professionals, existence
- Dementia training for police and fire services, existence
- Dementia training for retail and hospitality staff
- Dementia training for school children, existence
- Dementia training for volunteers, existence
- Dementia training: inclusion of basic dementia competencies in training of nurses
- Dementia training: inclusion of basic dementia competencies in training of personal support workers
- Dementia training: inclusion of basic dementia competencies in training of pharmaceutical personnel
- Dementia training: inclusion of basic dementia competencies in training of physicians
- Dementia training: inclusion of basic dementia competencies in training of social workers
- Dementia training: inclusion of basic dementia competencies in training of specialists
- Dementia treatment and support of carers and families of people with dementia
- Dementia workforce: geriatricians or psychogeriatricians (per 100,000)
- Dementia workforce: neurologists (per 100,000)
- Dementia workforce: personal care workers, number
- Dementia: Adult day centres
- Dementia: advance care directives, power of attorney or guardianship for people with dementia, existence of standards/ guidelines/ protocols
- Dementia: care in nursing & residential care facilities for people with dementia, existence of standards/ guidelines/ protocols
- Dementia: implementation level [national/subnational] of dementia awareness campaign
- Dementia: implementation level [national/subnational] of dementia care coordination
- Dementia: implementation level [national/subnational] of dementia carer support services
- Dementia: implementation level [national/subnational] of dementia legislation
- Dementia: implementation level [national/subnational] of dementia research plan/programme
- Dementia: implementation level [national/subnational] of dementia risk reduction campaign
- Dementia: implementation level [national/subnational] of research plan in which dementia is integrated
- Dementia: implementation level of dementia standards/ guidelines/ protocols (National)
- Dementia: implementation level of dementia standards/ guidelines/ protocols (Sub-national)
- Dementia: legislation for advanced care directives for people with dementia, existence
- Dementia: legislation for supported decision making for people with dementia, existence
- Dementia: legislation to end coercive practices for people with dementia
- Dementia: legislation to end discrimination against carers of people with dementia, existence
- Dementia: legislation to end discrimination against people with dementia, existence
- Dementia: routine monitoring of people with dementia
- Dementia-friendly initiative for assistance with home modification, existence
- Dementia-friendly initiative supporting community places for older people, existence
- Dementia-friendly initiative supporting social opportunities, existence
- Dementia-friendly initiative to improve accessibility of public spaces, existence
- Dementia-friendly initiative to improve accessibility of public transportation, existence
- Dementia-friendly initiative with assistive technology for loss of capacity, existence
- Dementia-friendly initiatives that improve accessibility, availability
- Dental Assistants and Therapists (number)
- Dental healthcare in million (US$), total expenditure
- Dental Prosthetic Technicians (number)
- Dentists (number)
- Dentists (per 10 000 population)
- Depression, population-based prevalence, estimate (%)
- Diabetes treatment coverage
- Diabetes, prevalence (%)
- Diarrhoea DALYs from inadequate hygiene, number
- Diarrhoea DALYs from inadequate sanitation
- Diarrhoea DALYs from inadequate water, number
- Diarrhoea DALYs from inadequate water, sanitation and hygiene, number
- Diarrhoea deaths from inadequate hygiene
- Diarrhoea deaths from inadequate sanitation, number
- Diarrhoea deaths from inadequate water, number
- Diarrhoea deaths from inadequate water, sanitation and hygiene, number
- Diarrhoea receiving ORS, children aged <5 years (%)
- Diarrhoeai diseases from inadequate sanitation, attributable fraction
- Diarrhoeal disease from inadequate hygiene, attributable fraction
- Diarrhoeal diseases from inadequate water, sanitation and hygiene, attributable fraction
- Diarrhoeal diseases from inadequate water, attributable fraction
- Diphtheria - number of reported cases
- Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
- Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%)
- Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%)
- Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%)
- Domestic general government health expenditure (GGHE-D) per capita in US$
- Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%)
- Domestic private health expenditure (PVT-D) per capita in US$
- Dying between the exact ages 30 and 70 years from cardiovascular diseases, cancer, diabetes, or chronic respiratory diseases, probability (SDG 3.4.1)
E
- Electric field (kV/m), exposure limit
- Electric field (V/m), exposure limit
- Electrification of health-care facilities: Percentage of health-care facilities with no access to any electricity supply (%)
- Electrification of health-care facilities: Percentage of health-care facilities with reliable electricity supply (%)
- Electrification of health-care facilities: Percentage of health-care facilities with unreliable electricity supply (%)
- Electromagnetic fields exposure: specific absorption rate (SAR) (W/kg)
- Electromagnetic fields legislative status, existence
- Electromagnetic fields standards, existence
- Electromagnetic fields: Magnetic flux density (microT), exposure limit
- Electromagnetic fields: Power density (W/m²)
- Electromagnetic fields: Power frequency (Hz)
- Employment services for drug use disorders
- Environment attributable deaths
- Environment attributable disability-adjusted life years (DALYs)
- Environment attributable disability-adjusted life years (DALYs) (%)
- Environmental and Occupational Health and Hygiene Professionals (number)
- Environmental and Occupational Health Inspectors and Associates (number)
- Environment-attributable DALYs (per 100 000 population), age-standardized
- Environment-attributable deaths (per 100 000 population), age-standardized
- Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia
- External health expenditure (EXT) as percentage of current health expenditure (CHE) (%)
- External health expenditure (EXT) per capita in US$
F
- Family planning, need for family planning satisfied with modern methods, women of reproductive age (aged 15-49 years), proportion (SDG 3.7.1)
- Financial hardship: households further impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities - developed by WHO/Europe) (%, national)
- Financial hardship: Households impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities - developed by WHO/Europe) (%, national)
- Financial hardship: increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line - 60% of median daily per capita consumption or income (%, national, rural, urban)
- Financial hardship: increase in poverty gap due to household health expenditures, expressed as a proportion of the $ 3.20 a-day poverty line (%, national, rural, urban)
- Financial hardship: increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%, national, rural, urban)
- Financial hardship: increase in poverty gap due to household health expenditures, expressed as a proportion of the $2.15 a-day poverty line (%, national, rural, urban)
- Financial hardship: increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.65 a-day poverty line (%, national, rural, urban)
- Financial hardship: population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, national, rural, urban)
- Financial hardship: population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, regional, global total)
- Financial hardship: population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (millions, regional, global total)
- Financial hardship: population pushed below the $1.90 a day poverty line by household health expenditures (%, national, rural, urban)
- Financial hardship: population pushed below the $1.90 a day poverty line by household health expenditures (%, regional, global total)
- Financial hardship: population pushed below the $1.90 a day poverty line by household health expenditures (millions, regional, global total)
- Financial hardship: population pushed below the $2.15 a day poverty line by household health expenditures (%, national, rural, urban)
- Financial hardship: population pushed below the $2.15 a day poverty line by household health expenditures (%, regional, global total)
- Financial hardship: population pushed below the $2.15 a day poverty line by household health expenditures (millions, regional, global total)
- Financial hardship: population pushed below the $3.20 a day poverty line by household health expenditures (%, national, rural, urban)
- Financial hardship: population pushed below the $3.20 a day poverty line by household health expenditures (%, regional, global total)
- Financial hardship: population pushed below the $3.20 a day poverty line by household health expenditures (millions, regional, global total)
- Financial hardship: population pushed below the $3.65 a day poverty line by household health expenditures (%, national, rural, urban)
- Financial hardship: population pushed below the $3.65 a day poverty line by household health expenditures (%, regional, global total)
- Financial hardship: population pushed below the $3.65 a day poverty line by household health expenditures (millions, regional, global total)
- Financial hardship: population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, national, rural, urban)
- Financial hardship: population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, regional, global total)
- Financial hardship: population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (millions, regional, global)
- Financial hardship: population pushed further below the $1.90 a day poverty line by household health expenditures (%, national, rural, urban)
- Financial hardship: population pushed further below the $2.15 a day poverty line by household health expenditures (%, national, rural, urban)
- Financial hardship: population pushed further below the $2.15 a day poverty line by household health expenditures (millions, regional, global total)
- Financial hardship: population pushed further below the $3.20 a day poverty line by household health expenditures (%, national, rural, urban)
- Financial hardship: population pushed further below the $3.65 a day poverty line by household health expenditures (%, national, rural, urban)
- Financial hardship: population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (%, national, rural, urban)
- Financial hardship: population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (%, regional, global total)
- Financial hardship: population with household expenditures on health greater than 10% of total household expenditure or income (SDG indicator 3.8.2) (millions, global, regional total)
- Financial hardship: population with household expenditures on health greater than 25% of total household expenditure or income ( SDG indicator 3.8.2) (%, regional, global total)
- Financial hardship: population with household expenditures on health greater than 25% of total household expenditure or income (SDG indicator 3.8.2) (%, national, rural, urban)
- Financial hardship: population with household expenditures on health greater than 25% of total household expenditure or income (SDG indicator 3.8.2) (millions, regional, global total)
- Financial hardship: total population pushed further below the $1.90 a day poverty line by household health expenditures (%, regional, global)
- Financial hardship: total population pushed further below the $1.90 a day poverty line by household health expenditures (millions, regional, global)
- Financial hardship: total population pushed further below the $2.15 a day poverty line by household health expenditures (%, regional,global)
- Financial hardship: total population pushed further below the $3.20 a day poverty line by household health expenditures (%, regional, global)
- Financial hardship: total population pushed further below the $3.20 a day poverty line by household health expenditures (millions, regional, global)
- Financial hardship: total population pushed further below the $3.65 a day poverty line by household health expenditures (%, regional, global)
- Financial hardship: total population pushed further below the $3.65 a day poverty line by household health expenditures (millions, regional, global)
- Food safety IHR core capacity
- Food safety score (JEE)
- Foodborne deaths (median, 95% uncertainty interval)
- Foodborne deaths per 100 000 (median, 95% uncertainty interval)
- Foodborne disability-adjusted life years (median, 95% uncertainty interval)
- Foodborne disability-adjusted life years per 100 000 (median, 95% uncertainty interval)
- Foodborne disability-adjusted life years per case (median, 95% uncertainty interval)
- Foodborne illnesses (median, 95% uncertainty interval)
- Foodborne illnesses per 100 000 (median, 95% uncertainty interval)
- Foodborne years lived with disability (median, 95% uncertainty interval)
- Foodborne years lived with disability per 100 000 (median, 95% uncertainty interval)
- Foodborne years lived with disability per case (median, 95% uncertainty interval)
- Foodborne years of life lost (median, 95% uncertainty interval)
- Foodborne years of life lost per 100 000 (median, 95% uncertainty interval)
- Foodborne years of life lost per case (median, 95% uncertainty interval)
H
- Health infrastructure: district/rural hospitals, density per 100 000 population
- Health infrastructure: health centres, density per 100 000 population
- Health infrastructure: Health posts density per 100 000 population
- Health infrastructure: hospitals, density per 100 000 population
- Health infrastructure: provincial hospitals, density per 100 000 population
- Health infrastructure: specialized hospitals density per 100 000
- Health technology for high burden diseases, type of lists that recommend
- Healthy life expectancy (HALE) at age 60 (years)
- Healthy life expectancy (HALE) at birth (years)
- Hepatitis - chronic hepatitis treatment rate as percentage of diagnosed
- Hepatitis - chronic hepatitis treatment rate as percentage of total infected
- Hepatitis - deaths caused by chronic hepatitis B and C (per 100 000)
- Hepatitis - deaths caused by chronic hepatitis, number
- Hepatitis - new infections
- Hepatitis - number of chronic hepatitis B-infected persons treated
- Hepatitis - number of chronic hepatitis-infected persons diagnosed
- Hepatitis - number of persons initiated hepatitis C treatment, latest year and cumulative over a period of years
- Hepatitis - number of persons living with chronic hepatitis
- Hepatitis - prevalence of chronic hepatitis among the general population
- Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
- Hepatitis B surface antigen (HBsAg)
- Hepatitis counselling and treatment availability in specialized facilities and services
- Hepatitis- diagnosis coverage of chronic hepatitis (HBV and HCV) as a percentage of infected
- Hib (Hib3) immunization coverage among 1-year-olds (%)
- HIV – Estimated antiretroviral therapy coverage among children
- HIV – Estimated antiretroviral therapy coverage among people living with HIV (%)
- HIV – Estimated number of children living with HIV
- HIV – Estimated number of pregnant women living with HIV
- HIV – Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
- HIV – New HIV infections (per 1000 uninfected population)
- HIV – New HIV infections among adults 15-24 years old (per 1000 uninfected population)
- HIV – Number of new HIV infections
- HIV – Number of people dying from HIV-related causes
- HIV – Number of people living with HIV
- HIV – Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
- HIV – Prevalence of HIV among adults aged 15 to 49 (%)
- HIV – Reported number of children receiving antiretroviral therapy
- HIV – Reported number of people receiving antiretroviral therapy
- HIV – Reported number of people receiving antiretroviral therapy, month and year of report
- HIV – testing and counselling facilities
- HIV – testing volume and positivity
- HIV test received: tests performed where results were received by a person (testing volume) (per 1000 population), estimate
- HIV-positive TB patients on ART (antiretroviral therapy) (%)
- Homicides rate (per 100 000 population), estimate
- Homicides, number, estimate
- Households pushed below or further below a relative poverty line (reflecting basic needs: food, housing, utilities - developed by WHO/Europe) by out-of-pocket payments (%, national)
- Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO/Europe) (%, national)
- HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%)
- Human African trypanosomiasis (T.b. gambiense), cases, reported number
- Human African trypanosomiasis (T.b. gambiense), new reported cases, number
- Human African trypanosomiasis (T.b. rhodesiense),new cases, reported number
- Hypertension among adults aged 30-79 years (%)
- Hypertension: diagnosis coverage among adults aged 30-79 with hypertension (%)
- Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension (%)
- Hypertension: raised blood pressure (uncontrolled hypertension) among adults aged 30-79 years (%)
- Hypertension: treatment coverage among adults aged 30-79 with hypertension (%)
I
L
- Lead paint: legally-binding controls on lead paint
- Leishmaniasis, cutaneous cases, reported number
- Leishmaniasis, cutaneous imported cases, reported number
- Leishmaniasis, cutaneous, status of endemicity
- Leishmaniasis, visceral cases, reported number
- Leishmaniasis, visceral imported cases, reported number
- Leishmaniasis, visceral, status of endemicity
- Leprosy - New cases detection rate per 1 000 000 population
- Leprosy - New leprosy cases with G2D rate per 1 000 000 population
- Leprosy - New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population
- Leprosy - Number of cases registered for treatment (prevalence)
- Leprosy - Number of new leprosy cases among children (less than 15 years of age)
- Leprosy - Number of new leprosy cases among females
- Leprosy - Number of new leprosy cases with G2D
- Leprosy - Number of new leprosy cases with G2D among children (less than 15 years of age)
- Leprosy - Registered prevalence rate per 1 000 000 population
- Leprosy cases, new, number
- Life expectancy at age 60 (years)
- Life expectancy at birth (years)
- Live birth health check: health check within 2 days after delivery of most recent live birth in the last 2 years, women age 15-49 years who received(%)
- Low birthweight number (in thousands)
- Low birthweight prevalence (%)
- Lymphatic filariasis
M
- Malaria cases (presumed + confirmed cases), total, number
- Malaria cases treated with artemisinin-based combination therapies (ACTs), number
- Malaria cases, confirmed, number
- Malaria cases, imported, number
- Malaria cases, indigenous, number
- Malaria cases, number, estimate
- Malaria cases, P. falciparum, indigenous, number
- Malaria cases, P. vivax, indigenous, number
- Malaria cases, presumed, number
- Malaria cases, status of indigenous cases
- Malaria cases, suspected, number
- Malaria deaths, number, estimate
- Malaria incidence (per 1000 population at risk), estimate
- Malaria mortality rate (per 100 000 population), estimate
- Malaria positive cases by microscopy, number
- Malaria positive cases by rapid diagnostic test (RDT), number
- Malaria protection, people protected from malaria by indoor residual spraying (IRS), number
- Malaria protection: insecticide-treated bed net (ITN) , population with access (%), modelled
- Malaria suspects examined by microscopy, number
- Malaria suspects examined by rapid diagnostic test (RDT), number
- Malaria treatment IPTp3: pregnant women attending antenatal care at least once and receiving at least 3 doses of Intermittent Preventive Treatment of Malaria for Pregnant Women (IPTp3) (%)
- Malaria treatment, cases treated with any first line tx courses (including artemisinin-based combination therapies (ACTs)), number
- Maternal deaths, number
- Maternal mortality ratio (per 100 000 live births)
- Maximum speed limits
- Measles - number of reported cases
- Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
- Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%)
- Medical and Pathology Laboratory scientists (number)
- Medical and Pathology Laboratory Technicians (number)
- Medical device: computed tomography units (per million population), total density
- Medical device: health technology national policy
- Medical devices assessment: national Health Technology Assessment (HTA) unit performing the assessment of medical devices including in vitro diagnostics.
- Medical devices procurement: national guidelines, policies or recommendations
- Medical devices procurement: national list of approved medical devices for procurement or reimbursement, availability
- Medical devices technical specifications to support procurement or donations, availability
- Medical devices: gamma camera or nuclear medicine (per million population), total density
- Medical devices: linear accelerator (per million population) total density
- Medical devices: magnetic resonance imaging units (per million population), total density
- Medical devices: mammography units (per million females aged from 50 to 69 years old), total density
- Medical devices: national authority responsible for regulating
- Medical devices: national standards or recommended lists, availability
- Medical devices: nomenclature system
- Medical devices: positron emission tomography (per million population), total density
- Medical devices: procurement of medical devices carried out at the national level
- Medical devices: radiotherapy units (per million population), total density
- Medical devices: telecobalt Unit (per million population), total density
- Medical devices: unit in the Ministry of Health responsible for the management of medical devices
- Medical devices: use of nomenclature system
- Medical doctor: generalist medical practitioners (number)
- Medical doctors (number)
- Medical doctors (per 10 000 population)
- Medical doctors by sex (%)
- Medical doctors not further defined (number)
- Medical doctors: specialist medical practitioners (number)
- Medicines, essential medicines: health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis, proportion
- Mental health care delivery
- Mental health community residential facilities (per 100 000)
- Mental health day treatment facilities (per 100 000)
- Mental health governance: government expenditures on mental health as a percentage of total government expenditures on health (%)
- Mental health governance: government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)
- Mental health governance: policy and financing
- Mental health outpatient facilities (per 100 000)
- Mental health outpatient visits (per 100,000)
- Mental health plan
- Mental health policy
- Mental health services: social workers working in mental health sector (per 100 000)
- Mental health units in general hospitals (per 100 000)
- Mental health units in general hospitals admissions (per 100 000)
- Mental health: beds in community residential facilities (per 100,000)
- Mental health: beds in mental hospitals (per 100,000)
- Mental health: nurses working in mental health sector (per 100 000)
- Mental health: other non-specialized doctors in mental health sector (per 100,000)
- Mental health: stand-alone legislation
- Mental health: stand-alone policy or plan
- Mental health: beds for mental health in general hospitals (per 100,000)
- Mental hospital admissions (per 100 000)
- Mental hospitals (per 100 000)
- Midwifery personnel (number)
- Mumps - number of reported cases
N
- NCD country capacity guidelines
- NCD country capacity infrastructure
- NCD country capacity progress monitor
- NCD country capacity rehabilitation availability
- NCD country capacity surveillance
- NCD country capacity survey indicators last updated in 2020
- NCD country capacity targets
- NCD country capacity: oral health
- NCD country capacity: policies, strategies and plans
- NCD country capacity: primary and secondary prevention of cancer
- NCD country capacity: procedures for NCD management at higher levels of the public health system
- NCD country capacity: sensory functions
- NCD country capacity: tests and procedures in primary health care
- NCD deaths: premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths
- NCD-related medicines
- Noncommunicable disease (NCD) deaths, number
- Noncommunicable disease (NCD) mortality rate (per 100 000 population), age-standardized
- NTD interventions, people requiring interventions against NTDs, number
- Nursing and midwifery personnel (number)
- Nursing and midwifery personnel (per 10 000 population)
- Nursing personnel (number)
- Nursing personnel by sex (%)
O
- Obesity among adults, BMI >= 30, prevalence (age-standardized estimate) (%)
- Obesity among adults, BMI >= 30, prevalence (crude estimate) (%)
- Obesity among children and adolescents, BMI > +2 standard deviations above the median, prevalence (crude estimate) (%)
- Occupational airborne particulates attributable DALYs ('000)
- Occupational airborne particulates attributable DALYs per 100'000 capita
- Occupational airborne particulates attributable deaths
- Occupational airborne particulates attributable deaths per 100'000 capita
- Occupational carcinogens attributable DALYs ('000)
- Occupational carcinogens attributable DALYs per 100'000 capita
- Occupational carcinogens attributable deaths
- Occupational carcinogens attributable deaths per 100'000 capita
- Occupational ergonomic stressors attributable DALYs ('000)
- Occupational ergonomic stressors attributable DALYs per 100'000 capita
- Occupational ergonomic stressors attributable deaths
- Occupational ergonomic stressors attributable deaths per 100'000 capita
- Occupational health and safety for health workers, national policy instruments, existence
- Occupational injuries attributable DALYs ('000)
- Occupational injuries attributable DALYs per 100'000 capita
- Occupational injuries attributable deaths
- Occupational injuries attributable deaths per 100'000 capita
- Occupational noise attributable DALYs ('000)
- Occupational noise attributable DALYs per 100'000 capita
- Occupational therapists in mental health sector (per 100,000)
- Official development assistance (ODA) to medical research and basic health sectors per capita (US$), total net, by recipient country
- Onchocerciasis preventive chemotherapy, invididuals requiring, number, estimate
- Onchocerciasis, status of endemicity
- Onchocerciasis: individuals treated for onchocerciasis, reported number
- Opioid dependence medication: naloxone availability
- Opioid dependence pharmacotherapy with methadone
- Oral diseases: productivity losses due to 5 oral diseases in million (US$), total
- Oral health : dental healthcare expenditure, per capita (US$)
- Oral health care rehabilitation as part of health benefit packages
- Oral health care, essential curative
- Oral health care, routine and preventive
- Oral health care: Advanced curative oral health care
- Oral health coverage of the largest government health financing scheme
- Oral health screening for early detection of oral diseases
- Oral health: basic restorative dental procedures to treat existing dental decay
- Oral health: Caries, untreated of permanent teeth in people 5+ years, prevalence
- Oral health: Caries, untreated, of deciduous teeth in children 1-9 years, prevalence
- Oral health: dedicated staff for oral health working on NCDs at the MoH, presence
- Oral health: Dental prosthetic technicians (per 10 000 population)
- Oral health: edentulism in people 20+ years, prevalence (%)
- Oral health: flouride toothpaste, number of labour days needed to buy annual supply of fluoride toothpaste per person
- Oral health: fluoride toothpaste, affordability
- Oral health: lip and oral cavity cancer new cases, number
- Oral health: lip and oral cavity cancer, incidence rate (per 100 000 population)
- Oral health: Noma recognized as a national public health problem
- Oral health: Per capita availability of sugar (g/day)
- Oral health: severe periodontal disease in people 15+ years, prevalence (%)
- Oral health: urgent treatment for providing emergency oral care and pain relief
- Out-of-pocket expenditure (OOP) per capita in US$
- Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%)
- Overweight among adults, BMI >= 25, prevalence (crude estimate) (%)
- Overweight among adults, BMI >= 25, prevalence (age-standardized estimate) (%)
- Overweight among children and adolescents, BMI > +1 standard deviations above the median, prevalence (crude estimate) (%)
- Overweight among children under 5 years of age (number in thousands) (model-based estimates)
- Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD) (model-based estimates)
- Overweight prevalence among children under 5 years of age (%) (% weight-for-height >+2 SD) (survey-based estimates)
P
- Patient safety core indicator aggregate, by region
- Patient safety core indicator survey response, by country
- Patient safety strategic objective aggregate, overall implementation of strategies, by region
- Patient safety strategy score, by region, per strategy
- Pertussis - number of reported cases
- Pharmaceutical Technicians and Assistants (number)
- Pharmacists (number)
- Pharmacists (per 10 000 population)
- Physical activity, insufficient, among adults aged 18+ years (crude estimate), prevalence (%)
- Physical activity, insufficient, among adults aged 18+ years, prevalence (age-standardized estimate) (%)
- Physical activity, insufficient, among school going adolescents aged 11-17 years (crude estimate), prevalence (%)
- Physiotherapists (number)
- Physiotherapy Technicians and Assistants (number)
- Pinta, status of endemicity
- Pneumococcal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)
- Poisoning (unintentional) - attributed mortality rate (per 100 000 population)
- Polio (Pol3) immunization coverage among 1-year-olds (%)
- Poliomyelitis - number of reported cases
- Poliomyelitis by wild polio virus cases, (WPV type 1), reported
- Psychiatrists working in mental health sector (per 100 000)
- Psychologists working in mental health sector (per 100 000)
R
- Rabies deaths in humans, reported, number
- Radon activities: concentration levels, national
- Radon activity: any national radon activity, existence
- Radon activity: any subnational radon activity, existence
- Radon concentration measurements for existing buildings
- Radon concentration measurements for new buildings
- Radon concentration measurements for workplaces (PHE: Radon database)
- Radon data exists in national radon database
- Radon in building regulations for existing buildings i.e. renovation/remodeling/major alteration
- Radon in building regulations for new buildings
- Radon in national drinking-water regulations
- Radon measurement providers, authorization/accreditation required
- Radon measurements, official protocols, existence
- Radon nation survey(s), existence
- Radon national action plan, existence
- Radon national database, existence
- Radon national map, existence
- Radon national reference level for buildings with high public occupancy, existence
- Radon national reference level for dwellings, existence
- Radon national reference level for workplaces, existence
- Radon national regulations, existence
- Radon national risk communication strategy, existence
- Radon prevention and mitigation systems service providers, authorization required
- Radon prevention: training for mitigation providers, existence
- Radon reference level for buildings with high public occupancy (Bq/m3)
- Radon reference level for dwellings (Bq/m3)
- Radon reference level for workplaces (Bq/m3)
- Radon standards/guidelines for prevention/mitigation
- Radon: financial support provided for mitigation (existing dwellings)
- Radon: inclusion of radon education for building professionals
- Radon: inclusion of radon in different national strategies
- Radon: inclusion of radon measurements in property transactions
- Radon: mandatory mitigation measures if legal value is exceeded (existing buildings)
- Radon: mandatory preventive measures (new buildings)
- Road safety definition of drink driving by Blood Alcohol Concentratio (BAC), existence
- Road safety funding for national strategy, availability
- Road safety lead agency, existence
- Road safety motorcycle helmet law, applicability to all occupants
- Road safety national speed limits, existence
- Road safety policy: vehicle standards
- Road safety seat-belt law, applicability to all occupants
- Road safety: Blood Alcohol Concentration (BAC) limit for drivers
- Road safety: law requires helmet to be fastened
- Road safety: national child-restraint law, existence
- Road safety: national drink-driving law, existence
- Road safety: national seat-belt law, existence
- Road safety: national strategy, existence
- Road safety: registered vehicles, number
- Road safety: seat-belt wearing rate (%)
- Road safety: universal access telephone number for pre-hospital care, existence
- Road traffic death rate (per 100 000 population), estimate
- Road traffic deaths due to alcohol, attribution (%)
- Road traffic deaths, distribution by type of road user (%)
- Road traffic deaths, number, estimate
- Road traffic injuries, age-standardized death rates (15+), per 100,000 population
- Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)
- Rubella - number of reported cases
S
- Severe wasting among children under 5 years of age (number in thousands) (JME)
- Severe wasting among children under 5 years of age (% weight-for-height <-3 SD) (survey-based estimates)
- Severe wasting prevalence among children under 5 years of age (%) (JME)
- Solar ultraviolet (UV) radiation exposure
- STI: Incident cases of chlamydia in 15- 49 year olds (in thousands)
- STI: Incident cases of chlamydia in 15- 49 year olds (per 1000)
- STI: Incident cases of gonorrhoea in 15- 49 year olds (in thousands)
- STI: Incident cases of gonorrhoea in 15- 49 year olds (per 1000)
- STI: Incident cases of syphilis in 15-49 year olds (in thousands)
- STI: Incident cases of trichomoniasis in 15- 49 year olds (in thousands)
- STI: Incident cases of trichomoniasis in 15- 49 year olds (per 1000)
- STI: Incident rate of active syphilis in 15-49 year olds (per 1000)
- STI: Prevalence of active syphilis in 15-49 year olds (%)
- STI: Prevalence of chlamydia in15- 49 year olds (%)
- STI: Prevalence of gonorrhoea in 15- 49 year olds (%)
- STI: Prevalence of trichomoniasis in 15- 49 year olds (%)
- STI: Prevalent cases of active syphilis in 15-49 year olds (in thousands)
- STI: Prevalent cases of chlamydia in 15- 49 year olds (in thousands)
- STI: Prevalent cases of gonorrhoea in 15- 49 year olds (in thousands)
- STI: Prevalent cases of trichomoniasis in 15- 49 year olds (in thousands)
- Stillbirth rate (per 1000 total births)
- Stunting among children under 5 years of age (number in thousands) (model-based estimates)
- Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD) (survey-based estimates)
- Stunting prevalence among children under 5 years of age (%) (model-based estimates)
- Substance use disorder : contact coverage of treatment services for substance use disorders (%)
- Substance use disorder: screening and brief intervention for substance use in primary health care
- Substance Use Disorders (SCI-SUD): Service Capacity Index
- Substance use disorders governance policy/action plan/ legislation, availability
- Substance use disorders service coverage: access to medicine progress
- Substance use disorders service governance progress
- Substance use disorders treatment, government resources, 5-year change
- Substance use disorders treatment: international cooperation, 5-year change
- Substance use disorders: compulsory treatment for people with alcohol use disorders in the criminal justice system
- Substance use disorders: compulsory treatment for people with drug use disorders in the criminal justice system
- Substance use disorders: continuing professional development in prevention
- Substance use disorders: Continuing professional development in treatment
- Substance use disorders: educational attainment in prevention
- Substance use disorders: educational attainment in treatment
- Substance use disorders: employment services for alcohol use disorders
- Substance use disorders: epidemiological data collection
- Substance use disorders: epidemiological data collection system for substance use among children and adolescents
- Substance use disorders: financing methods for treatment for alcohol use disorders
- Substance use disorders: financing methods for treatment for drug use disorders
- Substance use disorders: government benefits for people with alcohol use disorders
- Substance use disorders: government benefits for people with drug use disorders
- Substance use disorders: health information system progress
- Substance use disorders: health professionals providing treatment for alcohol and drug use disorders
- Substance use disorders: hypothecated taxes to be spent on prevention and treatment
- Substance use disorders: information on governmental support available
- Substance use disorders: involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs
- Substance use disorders: involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders
- Substance use disorders: involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs
- Substance use disorders: involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders
- Substance use disorders: main sector for treatment for alcohol use disorders
- Substance use disorders: main sector for treatment for drug use disorders
- Substance use disorders: medicine provided for free in public health care
- Substance use disorders: ministry/office that takes primary responsibility for prevention for substance use
- Substance use disorders: ministry/office that takes primary responsibility for treatment of substance use disorders
- Substance use disorders: non-structured services
- Substance use disorders: open access interventions for alcohol
- Substance use disorders: open access interventions for drugs
- Substance use disorders: pharmacological treatment guidelines
- Substance use disorders: pharmacological treatment services progress
- Substance use disorders: pharmacological treatment, access restrictions to maintenance treatment
- Substance use disorders: pharmacotherapy with buprenorphine
- Substance use disorders: pharmacotherapy with buprenorphine/naloxone
- Substance use disorders: postgraduate training programme in prevention
- Substance use disorders: postgraduate training programme in treatment
- Substance use disorders: prevention programmes for alcohol
- Substance use disorders: prevention programmes for drugs
- Substance use disorders: prevention programmes for specific populations for alcohol
- Substance use disorders: prevention programmes for specific populations for drugs
- Substance use disorders: prevention programs, groups and agencies involved
- Substance use disorders: prevention, government unit/official responsible
- Substance use disorders: programmes readily available
- Substance use disorders: psychosocial treatment services
- Substance use disorders: registration of medications for alcohol dependence and withdrawal
- Substance use disorders: registration of medications for opioid dependence
- Substance use disorders: registration of medications for opioid withdrawal
- Substance use disorders: registration of naloxone for injection for opioid overdose
- Substance use disorders: regular reports on epidemiological and service delivery data for substance use
- Substance use disorders: report with data from health services on alcohol use and AUDs
- Substance use disorders: report with epidemiological data on alcohol use and AUDs
- Substance use disorders: screening and brief intervention for substance use in antenatal services
- Substance use disorders: screening and brief interventions for substance use in antenatal services, recommendations
- Substance use disorders: screening and brief interventions for substance use in primary health care, recommendations
- Substance use disorders: self-help groups
- Substance use disorders: service delivery data collection for substance use
- Substance use disorders: special housing services for alcohol use disorders
- Substance use disorders: special housing services for drug use disorders
- Substance use disorders: special treatment programmes for gambling disorder
- Substance use disorders: specialized human workforce, availability and quantity
- Substance use disorders: specialized treatment facilities for alcohol use disorders
- Substance use disorders: specialized treatment facilities for drug use disorders
- Substance use disorders: specialized treatment facilities for substance use disorders
- Substance use disorders: standards of care for professionals providing treatment for alcohol and drug use disorders
- Substance use disorders: standards of treatment and care for public specialized treatment facilities
- Substance use disorders: system of monitoring alcohol involvement in forensic pathology
- Substance use disorders: system of monitoring drugs involvement in forensic pathology
- Substance use disorders: timeframe for maintenance treatment of opioid dependence
- Substance use disorders: treatment coverage for substance dependence, reported
- Substance use disorders: treatment programmes for children and adolescents with alcohol use disorders
- Substance use disorders: treatment programmes for children and adolescents with drug use disorders
- Substance use disorders: treatment programmes for women with alcohol use disorders
- Substance use disorders: treatment programmes for women with drug use disorders
- Substance use disorders: voluntary treatment for people with alcohol use disorders in the criminal justice system
- Substance use disorders: voluntary treatment for people with drug use disorders in the criminal justice system
- Substance use disordres: treatment, government unit/official responsible
- Substance use prevention: government resources, 5-year change
- Substance use prevention: international cooperation, 5-year change
- Substance use/ substance use disorders data prevalence
- Suicide rates (per 100 000), age-standardized
- Suicide rates, crude, (per 100 000 population) (SDG 3.4.2)
- Sunbed regulations: access restrictions and inspections
- Sunbed regulations: Existence of national regulations
- Sunbed regulations: Existence of subnational regulation
- Sunbed regulations: national regulations on public information, training and safety requirements
- Sunbed regulations: Restriction and inspection of facilities
- Sunbed regulations: Safety requirements
- Sunbed regulations: Training requirements
- Sunbed regulations: Year of national implementation of regulation
- Surgical workforce: anaesthesiologists, license qualified actively working
- Surgical workforce: obstetricians, licensed qualified actively working
- Surgical workforce: surgeons, licensed qualified actively working
- Syphilis ANC: Women accessing antenatal care (ANC) services who were tested for syphilis (%), reported
- Syphilis, antenatal care attendees positive for syphilis who received treatment (%), reported
- Syphilis, antenatal care attendees who were positive for syphilis (%), reported
T
- Taenia solium, status of endemicity
- Taenia solium: Number of pigs in the country
- Taenia solium: Presence of roaming backyard pigs
- Tax on alcoholic beverages: excise tax
- Tax: Alcohol content in beverage in percent of volume, (alcohol by volume) (ABV %)
- Tax: alcohol sale status
- Tax: Alcoholic beverage price
- Tax: Automatic adjustment of specific excise on alcoholic beverage
- Tax: Automatic adjustment of specific excise on non-alcoholic beverage
- Tax: Base for ad valorem excise tax on alcoholic beverage
- Tax: Base for ad valorem excise tax on non-alcoholic beverages
- Tax: Excise taxes are applied on alcoholic beverages
- Tax: Excise taxes are applied on non-alcoholic beverages
- Tax: Excise taxes on alcoholic beverages
- Tax: Excise taxes on non-alcoholic beverages
- Tax: Import duties on alcoholic beverages
- Tax: Import duties on non-alcoholic beverages
- Tax: Most sold type of spirit
- Tax: Non-alcoholic beverage price
- Tax: Other taxes on alcoholic beverages
- Tax: Other taxes on non-alcoholic beverages
- Tax: Sugar-content of beverage per 100ml
- Tax: Total taxes on alcoholic beverages
- Tax: Total taxes on non-alcoholic beverages
- Tax: Type of excise tax applied on alcoholic beverage
- Tax: Type of excise tax applied on non-alcoholic beverage
- Tax: Uniform or tiered excise tax system applied on alcoholic beverage. If tiered on the beverage, the tiers are alcohol-based
- Tax: Uniform or tiered excise tax system applied on non-alcoholic beverage. If tiered on the beverage, the tiers are sugar-content-based
- Tax: Use of earmarked excise tax on alcoholic beverages
- Tax: Use of earmarked excise tax on non-alcoholic beverages
- Tax: Value-added/sales tax on alcoholic beverages
- Tax: Value-added/sales tax on non-alcoholic beverages
- Tetanus - number of reported cases
- Tetanus protection for neonates, neonates protected at birth against neonatal tetanus (PAB) (%)
- Tetanus, neonatal tetanus - number of reported cases
- Thinness among children and adolescents, BMI < -2 standard deviations below the median, prevalence (crude estimate) (%)
- Tobacco advertising ban at point of sale
- Tobacco advertising ban in international magazines and newspapers
- Tobacco advertising ban in local magazines and newspapers
- Tobacco advertising ban on international television and radio
- Tobacco advertising ban: ban on identifying non-tobacco products with tobacco brand names
- Tobacco advertising ban: Corporate Social Responsibility activities (CSR)
- Tobacco advertising ban: display of tobacco products at points of sale
- Tobacco advertising ban: entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry
- Tobacco advertising ban: promotional discounts
- Tobacco advertising ban: publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals
- Tobacco advertising ban: tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth
- Tobacco advertising ban: tobacco companies/the tobacco industry publicizing their CSR activities
- Tobacco advertising ban: tobacco vending machines
- Tobacco advertising ban: free distribution in mail or through other means
- Tobacco affordability
- Tobacco anti-tobacco campaign: outcome evaluation was employed to assess effectiveness of the campaign
- Tobacco anti-tobacco campaign: process evaluation was employed to assess implementation of the campaign
- Tobacco anti-tobacco mass media campaign: at least one national campaign ran during survey period
- Tobacco anti-tobacco mass media campaigns
- Tobacco ban on advertising on national television and radio
- Tobacco ban on advertising on the internet
- Tobacco ban on advertising: any form of contribution (financial or other support) to any event, activity or individual
- Tobacco ban on advertising: appearance of tobacco products in TV and/or films
- Tobacco ban on advertising: billboard and outdoor advertising
- Tobacco ban on advertising: on appearance of tobacco brands in TV and/or films (product placement)
- Tobacco ban on sponsorship (contributions and/or publicity of contributions)
- Tobacco ban on use of brand name of non-tobacco product for tobacco product
- Tobacco bans: compliance with bans on direct advertising (score) , overall
- Tobacco bans: compliance with bans on promotion and sponsorship (score), overall
- Tobacco bans: subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place
- Tobacco bans: subnational bans on tobacco advertising, promotion and sponsorship authority exists
- Tobacco compliance scores: advertising promotion and sponsorship bans
- Tobacco compliance scores: smoke-free legislation
- Tobacco control offer help: Access to a toll-free quit line
- Tobacco control: Enforce bans: Law requires fines for violations of advertising bans
- Tobacco control: Enforce bans: Law requires fines for violations of promotion and sponsorship bans
- Tobacco control: Monitor: current tobacco use, tobacco smoking and cigarette smoking, estimate, non-age-standardized
- Tobacco control: Monitor: national tobacco control programmes
- Tobacco control: MPOWER monitoring tobacco use and prevention policies
- Tobacco enforce bans: anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images, required
- Tobacco health warnings appear on cigarette packages, law mandates
- Tobacco health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale
- Tobacco health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale
- Tobacco health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale
- Tobacco health warnings appear on other smoked tobacco packages, law mandates
- Tobacco health warnings appear on smokeless tobacco packages, law mandates
- Tobacco health warnings approved by the law for cigarette packaging
- Tobacco health warnings approved by the law for other smoked tobacco packaging
- Tobacco health warnings approved by the law for smokeless tobacco packaging (Tobacco control: Health warnings)
- Tobacco health warnings on cigarette packaging describe the harmful effects of tobacco use on health
- Tobacco health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
- Tobacco health warnings on cigarette packaging law applies to products whether manufactured domestically imported AND for duty-free sale
- Tobacco health warnings on cigarette packaging law requires or establishes fines for violations
- Tobacco health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
- Tobacco health warnings on cigarette packaging must be rotated
- Tobacco health warnings on cigarette packaging must be written in the principal language(s) of the country
- Tobacco health warnings on cigarette packaging must include a photograph or graphic
- Tobacco health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
- Tobacco health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry
- Tobacco health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
- Tobacco health warnings on other smoked tobacco packaging law requires or establishes fines for violations
- Tobacco health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package (Tobacco control: Health warnings)
- Tobacco health warnings on other smoked tobacco packaging must be rotated
- Tobacco health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country
- Tobacco health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps
- Tobacco health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
- Tobacco health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
- Tobacco health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
- Tobacco health warnings on smokeless tobacco packaging must be rotated
- Tobacco health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country
- Tobacco health warnings on smokeless tobacco packaging must include a photograph or graphic
- Tobacco health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
- Tobacco help: smoking cessation support is available in health clinics or other primary care facilities
- Tobacco help: smoking cessation support is available in hospitals
- Tobacco help: smoking cessation support is available in offices of health professionals
- Tobacco help: smoking cessation support is available in other settings
- Tobacco help: smoking cessation support is available in the community
- Tobacco inflation-adjusted prices in LCU and PPP
- Tobacco legislation: citizen complaints and investigations of smoke-free laws
- Tobacco medication legally sold: Bupropion
- Tobacco medication legally sold: Cytisine
- Tobacco medication legally sold: nicotine replacement therapy
- Tobacco medication place available: Bupropion
- Tobacco medication place available: Cytisine
- Tobacco medication place available: Nicotine replacement therapy
- Tobacco medication place available: varenicline
- Tobacco MPOWER Overview
- Tobacco MPOWER: Enforce bans on tobacco advertising, promotion and sponsorship
- Tobacco MPOWER: Offer help to quit tobacco use
- Tobacco MPOWER: Protecting people from tobacco smoke
- Tobacco MPOWER: Raise taxes on tobacco
- Tobacco national taxes and retail price for 1 ml of e-liquid of the cheapest brand of a closed disposable ENDS/ENNDS system, globally
- Tobacco national taxes and retail price for 1 ml of e-liquid of the cheapest brand of a closed rechargeable ENDS/ENNDS system
- Tobacco national taxes and retail price for 10 ml of e-liquid of the cheapest brand of an open ENDS/ENNDS system
- Tobacco national taxes and retail price for 20 grams of smokeless tobacco products
- Tobacco national taxes and retail price for 20 sticks of heated tobacco products
- Tobacco national taxes and retail price for a pack of 20 cigarettes (most sold brand)
- Tobacco national taxes and retail price for other smoked tobacco products
- Tobacco packaging, cigarettes: health warnings are mandated for cigarette packaging, font style, font size and colour
- Tobacco packaging, other smoked tobacco: health warnings are mandated for other smoked tobacco packaging, font style, font size and colour
- Tobacco packaging, smokeless tobacco: health warnings are mandated for smokeless tobacco packaging, font style, font size and colour
- Tobacco price dispersion: Share of cheapest brand price in premium brand price (%) (the higher the % the smaller the gap)
- Tobacco products annual tax revenues
- Tobacco retail price for a pack of 20 cigarettes: premium brand and cheapest brand
- Tobacco smoke-free education facilities except universities (national legislation) (Tobacco control: Protect)
- Tobacco smoke-free government facilities (national legislation)
- Tobacco smoke-free health care facilities (national legislation)
- Tobacco smoke-free indoor offices (national legislation)
- Tobacco smoke-free legislation authority exists, subnational
- Tobacco smoke-free other indoor public spaces (national legislation)
- Tobacco smoke-free places (national legislation), number
- Tobacco smoke-free public transport (national legislation)
- Tobacco smoke-free pubs, bars and cafes (national legislation)
- Tobacco smoke-free restaurants (national legislation)
- Tobacco smoke-free universities (national legislation)
- Tobacco smoking ban: dedicated funds for enforcement
- Tobacco smoking ban: fines for violations of smoke-free laws
- Tobacco smoking ban: fines on the establishment for violations of smoke-free laws
- Tobacco smoking ban: fines on the patrons of establishments for violations of smoke-free laws
- Tobacco survey details: smokeless tobacco use or e-cigarette use among adults
- Tobacco survey details: smokeless tobacco use or e-cigarettes among adults
- Tobacco survey details: tobacco use or smoking among adolescents
- Tobacco survey details: tobacco use or smoking among adults test
- Tobacco tax administration
- Tobacco tax revenues - currency reported (Tobacco control: Raise taxes)
- Tobacco tax revenues - tobacco product types included (Tobacco control: Raise taxes)
- Tobacco tax revenues - total excise (specific and ad valorem) (Tobacco control: Raise taxes)
- Tobacco tax revenues - total revenues (Tobacco control: Raise taxes)
- Tobacco tax revenues - valued added tax (VAT) and other sales taxes (Tobacco control: Raise taxes)
- Tobacco tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes and other tobacco products
- Tobacco tax structure and administration
- Tobacco tax structure/level
- Tobacco tax structure: a minimum price policy is implemented
- Tobacco tax structure: greater reliance on specific tax in mixed excise regime
- Tobacco tax structure: retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)
- Tobacco tax: minimum specific tax applied in ad valorem or mixed excise regime
- Tobacco tax: specific tax component automatically adjusted for inflation (or other)
- Tobacco tax: type of excise tax applied
- Tobacco tax: uniform excise tax applied Yes (Uniform), No (Tiered/varying rates)
- Tobacco tax: use earmarked tobacco taxes, reported
- Tobacco warn: specific health warnings are mandated for cigarette packaging
- Tobacco warn: specific health warnings are mandated for other smoked tobacco packaging
- Tobacco warn: specific health warnings are mandated for smokeless tobacco packaging
- Tobacco warning packaging of other smoked tobacco products is mandatory (ie. promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
- Tobacco warning: anti-tobacco campaign was part of a comprehensive tobacco control programme
- Tobacco warning: anti-tobacco campaign was pre-tested
- Tobacco warning: anti-tobacco mass media campaign, formative research was conducted prior
- Tobacco warning: back of cigarette packaging, percentage of principal display area mandated to be covered by health warnings
- Tobacco warning: back of other smoked tobacco packaging, percentage of principal display area mandated to be covered by health warnings
- Tobacco warning: back of smokeless tobacco packaging, percentage of principal display area mandated to be covered by health warnings
- Tobacco warning: Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
- Tobacco warning: cigarette packaging and labelling must not use descriptors depicting flavours
- Tobacco warning: cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
- Tobacco warning: Earned media/public relations were used to promote the anti-tobacco campaign
- Tobacco warning: front and back of cigarette packaging, percentage of principal display area mandated to be covered by health warnings
- Tobacco warning: front and back of other smoked tobacco packaging, percentage of principal display area mandated to be covered by health warnings
- Tobacco warning: front and back of smokeless tobacco packaging, percentage of principal display area mandated to be covered by health warnings
- Tobacco warning: front of cigarette packaging, percentage of principal display area mandated to be covered by health warnings
- Tobacco warning: front of other smoked tobacco packaging, percentage of principal display area mandated to be covered by health warnings -
- Tobacco warning: front of smokeless tobacco packaging, percentage of principal display area mandated to be covered by health warnings
- Tobacco warning: other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
- Tobacco warning: other smoked tobacco packaging and labelling must not use descriptors depicting flavours
- Tobacco warning: other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
- Tobacco warning: plain packaging of smokeless tobacco products is mandatory (ie. packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
- Tobacco warning: quit line number must appear on cigarette packaging or labelling
- Tobacco warning: quit line number must appear on other smoked tobacco packaging or labelling
- Tobacco warning: quit line number must appear on smokeless tobacco packaging or labelling
- Tobacco warning: smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
- Tobacco warning: smokeless tobacco packaging and labelling must not use descriptors depicting flavours
- Tobacco warning: smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
- Tobacco warning: warn about the dangers of tobacco
- Tobacco warnings: ban on deceitful terms on cigarette packaging
- Tobacco warnings: ban on deceitful terms on other smoked tobacco packaging
- Tobacco warnings: ban on deceitful terms on smokeless tobacco packaging
- Tobacco: affordability of cigarettes: category of change in the last 10 years
- Tobacco: cigarette affordability of most sold brand - percentage of GDP per capita required to purchase 2000 cigarettes
- Tobacco: cigarette most sold brand, affordability
- Tobacco: current tobacco use, tobacco smoking and cigarette smoking, age-standardized
- Tobacco: smokeless tobacco use or e-cigarette use among adolescents most recent nationally representative survey
- Total expenditure on health as a percentage of gross domestic product
- Total workforce in mental health sector (per 100,000)
- Trachoma as a public health problem, status of elimination
- Trachoma elimination as a public health problem: population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement
- Trachoma: people who received treatment with antibiotics for trachoma, number
- Trachomatous trichiasis, people operated on, number
- Traditional and Complementary Medicine Professionals (number)
- Tuberculosis (HIV-positive cases), incidence, (per 100 000 population)
- Tuberculosis : tested TB patients HIV-positive (%)
- Tuberculosis among HIV-negative people (per 100 000 population), deaths
- Tuberculosis cases started on MDR-TB treatment
- Tuberculosis deaths, excluding HIV, number
- Tuberculosis drug resistant TB: confirmed cases of RR-/MDR-TB
- Tuberculosis drug-resistant cases tested for RR-/MDR-TB, previously treated (%)
- Tuberculosis incidence (per 100 000 population per year)
- Tuberculosis incidence cases in children aged 0 - 14, number
- Tuberculosis incident cases
- Tuberculosis incident cases, (HIV-positive cases)
- Tuberculosis new and relapse cases
- Tuberculosis patients with known HIV status (%)
- Tuberculosis treatment coverage
- Tuberculosis treatment success rate for patients treated for MDR-TB (%)
- Tuberculosis treatment success rate: HIV-positive TB cases
- Tuberculosis treatment success rate: new TB cases
- Tuberculosis treatment success rate: previously treated TB cases
- Tuberculosis, drug resistant: new cases tested for RR-/MDR-TB (%)
- Tuberculosis: MDR/RR-TB incident cases, number, estimate
U
- UHC index of service coverage, data, availability
- UHC Service Coverage Index (SDG 3.8.1)
- UHC Service Coverage Index, primary data availability (SDG 3.8.1) (%)
- UHC Service Coverage sub-index on infectious diseases
- UHC Service Coverage sub-index on noncommunicable diseases
- UHC Service Coverage sub-index on reproductive, maternal, newborn and child health
- UHC Service Coverage sub-index on service capacity an access
- Underweight among adults, BMI < 18.5, prevalence (age-standardized estimate) (%)
- Underweight among adults, BMI < 18.5, prevalence (crude estimate) (%)
- Underweight among children under 5 years of age (number in thousands) (model-based estimates)
- Underweight prevalence among children under 5 years of age (% weight-for-age <-2 SD) (%) (survey-based estimates)
- Underweight prevalence among children under 5 years of age (%) (model-based estimates)
- Universal Health Coverage (UHC): countries that have passed legislation on
- UV radiation attributable DALYs ('000)
- UV radiation attributable DALYs per 100'000 capita
- UV radiation attributable deaths
- UV radiation attributable deaths per 100'000 capita
V
- Vaccination cards seen, proportion (%) (Immunization)
- Varenicline - legally sold (Tobacco control: Offer help)
- Violence against children: children aged 1-17 years who experienced any physical punishment and/or psychological aggression by caregivers in the past month, proportion (SDG 16.2.1)
- Violence against women and girls, intimate partner, ever-partnered women and girls aged 15-49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months, proportion
- Violence prevention: elder abuse caregiver-support programmes, extent of implementation of
- Violence victims: child protection services, extent of implementation
- Violence victims: implementation of mental health services for victims of all types of violence, extent
- Violence victims: medico-legal services for victims of sexual violence, extent of implementation
- Violence: child maltreatment, lifetime prevalence (%)
- Violence: intimate partner violence prevalence among ever partnered women in the previous 12 months (%)
- Violence: intimate partner violence prevalence among ever partnered women in their lifetime (%)
- Violence: intimate partner violence: Extent of implementation of dating violence prevention programmes
- Violence: Non-partner sexual violence prevalence (%)
- Vision and eyecare: effective refractive error coverage (eREC) (%)
W
- WASH basic drinking-water services, population using at least (%)
- WASH basic handwashing facilities at home, population (%)
- WASH basic sanitation services, population using at least (%)
- WASH exposure, defecation: population practising open defecation (%)
- WASH improved sanitation facilities, population using (%)
- WASH safely managed drinking-water services, population using (%)
- WASH safely managed sanitation services, population using (%)
- Wastewater flows, safely treated domestic wastewater flows, proportion SDG 6.3.1
- Wasting among children under 5 years of age (number in thousands) (JME)
- Wasting prevalence among children under 5 years of age (% weight-for-height <-2 SD) (survey-based estimates)
- Wasting prevalence among children under 5 years of age (%) (JME)
- Water- and sanitation-related ODA: Official development assistance that is part of a government-coordinated spending plan
- Water-, sanitation- and hygiene- attributable deaths (unsafe WASH services), number, SDG 3.9.2
- Water-, sanitation- and hygiene-attributed mortality rate, exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2)